Ebola virus survivors in Liberia experience a higher prevalence of certain health issues, including neurological sequelae and uveitis, compared with uninfected contacts who share similar environmental exposures, according to research published in The New England Journal of Medicine.

The PREVAIL III cohort study was initiated in June 2015 to determine long-term consequences of Ebola virus disease (EVD). Researchers compared the prevalence of symptoms and abnormal findings among survivors and controls at study entry and during follow-up examinations after 6 and 12 months.